BACTERIAL SPECTRUM AND ANTIBIOTIC RESISTANCE IN TUBO-OVARIAN ABSCESS CASES AT NHAN DAN GIA DINH’S HOSPITAL
Main Article Content
Abstract
Research Objective: To describe the bacterial spectrum and antibiotic resistance patterns in tubo-ovarian abscess (TOA) cases at Gia Dinh People's Hospital.Methods: A retrospective case series study was conducted, using convenience sampling of medical records (n=66) of patients diagnosed with tubo-ovarian abscess who underwent surgery or drainage accompanied by culture and antibiotic susceptibility testing. Data were collected from January 2021 to May 2025 at the Department of Obstetrics and Gynecology, Gia Dinh People's Hospital. Results: A total of 66 cases met the inclusion criteria, with a mean age of 44.6 ± 10.2 years. Among the 39 positive culture samples, the isolated pathogens included E. coli 19/39 (48.7%), Klebsiella pneumoniae 7/39 (17.9%), and Streptococcus spp. 9/39 (23.1%). Of these, 6/39 (15.4%) E. coli strains produced ESBL and 1/39 (2.6%) produced AmpC β-lactamase. The rate of polymicrobial infection was 21.9% (7/32 culture-positive cases). Both E. coli and K. pneumoniae strains were fully sensitive to ertapenem and imipenem (100%). However, they showed high resistance rates to ampicillin (93% in E. coli, 100% in K. pneumoniae) and ceftriaxone (50% in E. coli, 100% in K. pneumoniae). Additionally, E. coli demonstrated 43% resistance to levofloxacin. Conclusion: Tubo-ovarian abscess presents with a diverse bacterial spectrum, mainly consisting of enteric bacteria and anaerobic Gram-positive cocci. Consistent with previous reports, E. coli was the predominant pathogen. The high resistance rates to broad-spectrum antibiotics (such as cephalosporins and fluoroquinolones) highlight the need to develop tailored treatment regimens based on local resistance patterns.
Article Details
Keywords
tubo-ovarian abscess, bacterial spectrum, antibiotic resistance.
References
2. Kairys, N. and C. Roepke, Tubo-ovarian abscess, in StatPearls [Internet]. 2023, StatPearls Publishing.
3. Shigemi, D., et al., Laparoscopic compared with open surgery for severe pelvic inflammatory disease and tubo-ovarian abscess. 2019. 133(6): p. 1224-1230.
4. Workowski, K.A.J.M.R. and Reports, Sexually transmitted infections treatment guidelines, 2021. 2021. 70.
5. Micheli, G., et al., Microbiology and outcomes of tubo-ovarian abscesses: A 5-year cohort of 105 cases. J Infect, 2024. 89(5): p. 106253.
6. Organization, W.H., Global antimicrobial resistance and use surveillance system (GLASS) report 2022. 2022: World Health Organization.
7. Landers, D.V. and R.L.J.R.o.i.d. Sweet, Tubo-ovarian abscess: contemporary approach to management. 1983. 5(5): p. 876-884.
8. Tang, H., H. Zhou, and R. Zhang, Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess. Front Cell Infect Microbiol, 2022. 12: p. 958210.